<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Regulation of cell proliferation and motility is essential for <z:mpath ids='MPATH_458'>normal</z:mpath> development </plain></SENT>
<SENT sid="1" pm="."><plain>The Rho family of GTPases plays a critical role in the control of cell polarity and migration by effecting the cytoskeleton, membrane trafficking, and cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated a recognized <z:e sem="disease" ids="C0008073" disease_type="Mental or Behavioral Dysfunction" abbrv="">developmental disorder</z:e>, <z:e sem="disease" ids="C0265268" disease_type="Disease or Syndrome" abbrv="AOS">Adams-Oliver syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AOS</z:e>), characterized by the combination of <z:hpo ids='HP_0001057'>aplasia cutis congenita</z:hpo> (ACC) and terminal transverse limb defects (TTLD) </plain></SENT>
<SENT sid="3" pm="."><plain>Through a genome-wide linkage analysis, we detected a locus for <z:hpo ids='HP_0000006'>autosomal-dominant</z:hpo> ACC-TTLD on 3q generating a maximum LOD score of 4.93 at marker rs1464311 </plain></SENT>
<SENT sid="4" pm="."><plain>Candidate-gene- and exome-based sequencing led to the identification of independent premature truncating mutations in the terminal exon of the Rho GTPase-activating protein 31 gene, ARHGAP31, which encodes a Cdc42/Rac1 regulatory protein </plain></SENT>
<SENT sid="5" pm="."><plain>Mutant transcripts are stable and increase ARHGAP31 activity in vitro through a gain-of-function mechanism </plain></SENT>
<SENT sid="6" pm="."><plain>Constitutively active ARHGAP31 mutations result in a loss of available active Cdc42 and consequently disrupt actin cytoskeletal structures </plain></SENT>
<SENT sid="7" pm="."><plain>Arhgap31 expression in the mouse is substantially restricted to the terminal limb buds and craniofacial processes during early development; these locations closely mirror the sites of impaired organogenesis that characterize this syndrome </plain></SENT>
<SENT sid="8" pm="."><plain>These data identify the requirement for regulated Cdc42 and/or Rac1 signaling processes during early human development </plain></SENT>
</text></document>